Vicore Pharma Holding AB

VCRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.80

-$0.40 (-3.92%)

At close: Oct 30, 2026, 4:00 PM ET

$9.61

-$0.19 (-1.94%)

After-hours: Oct 30, 2026, 4:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $276.83M

Enterprise Value $2.59B

Beta 0.15

Average Volume 27.15K

Shares Outstanding (Diluted) 280.09M

Shares Change YoY 1093.97%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US92581R1041

Price Performance

Price Change 1M 3.0%

Price Change 3M -14.0%

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -5.3%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -79.6%

Valuation

PE Ratio -9.74

Forward PE N/A

PEG Ratio -0.31

Forward PEG -1.54

PS Ratio 1,945.57

Forward PS 1,026.80

PB Ratio 30.47

P/FCF Ratio -11.46

P/Adj. FCF Ratio -11.47

P/OCF Ratio -5.66

EV/Sales 1,946.73

EV/EBIT -9.80

EV/EBITDA -10.41

EV/FCF -11.46

Earnings Yield -9.9%

FCF Yield -8.4%

Adj. FCF Yield -8.4%

Financial Health

Net Cash kr93.41M

Total Debt kr0

Cash & Short-Term Investments kr93.41M

Total Assets kr95.91M

Current Ratio 12.68

Quick Ratio 12.68

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -52.06

Altman Z-Score 206.27

Piotroski F-Score 0

Margins & Profitability

Gross Profit Margin 81.0%

Operating Profit Margin -21455.4%

EBITDA Margin -13560.6%

Net Profit Margin -12569.8%

FCF Margin -16982.6%

Adj. FCF Margin -16961.0%

SBC / Revenue -67.6%

SBC Impact (per share) -0.1%

Returns

Return on Assets -54.0%

Return on Equity -53.7%

Return on Invested Capital -61.3%

Return on Capital Employed -61.3%

Return on Tangible Assets -54.0%

Historical Growth (CAGR)

Revenue CAGR 3Y -89.1%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -71.5%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -45.3%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 24.7%

Revenue Growth Next 3Y -43.0%

Earnings Date Aug 21, 2026

EPS Estimate (next Q) -$0.04

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $49.05K

Revenue Growth Est (next Q) -72.7%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25.00

Price Target Upside 155.1%

Cash Flow

Operating Cash Flow kr-225.86M

Free Cash Flow kr-225.86M

Adj. Free Cash Flow kr-225.58M

FCF Per Share -$10.64

OCF Per Share -$16.18

OCF/S Ratio -11402.8%

Income Statement

Revenue kr1.33M

Gross Profit kr1.33M

Operating Income kr-285.35M

EBITDA kr-248.71M

Net Income kr-272.5M

EPS (Diluted) -$9.40

Revenue / Employee $35.95K

Profit / Employee $-7.36M

Employees 37